Corbus Pharmaceuticals Holdings Inc (CRBP)
37.98
-0.79
(-2.04%)
USD |
NASDAQ |
May 06, 11:56
Corbus Pharmaceuticals Holdings Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2020 | 5.00M |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 |
| Date | Value |
|---|---|
| December 31, 2017 | |
| September 30, 2017 | 0.50M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 1.00M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
5.00M
Minimum
Jun 2020
5.00M
Maximum
Jun 2020
5.00M
Average
5.00M
Median
Jun 2020
Accounts Receivable (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -- |
| Perspective Therapeutics Inc | 1.165M |
| Protalix BioTherapeutics Inc | 5.272M |
| Electromed Inc | 22.99M |
| Armata Pharmaceuticals Inc | -- |